Registration statement for securities of certain foreign private issuers

Disposals of Subsidiaries

v3.21.2
Disposals of Subsidiaries
6 Months Ended
Jun. 30, 2021
Text block [abstract]  
Disposals of Subsidiaries
4.
Disposals of Subsidiaries
On January 14, 2021 the Group entered a Share Purchase Agreement (“SPA”) with TELUS Corporation (“TELUS”), a Canadian publicly traded holding company which is the parent of various telecommunication subsidiaries, for the sale of the Babylon Health Canada Limited business. The entire issued share capital of Babylon Health Canada Limited was transferred to TELUS for a base price of $1,800 thousand CAD, which has been adjusted for working capital and net indebtedness. A further $3,500 thousand payment was made by TELUS that was attributable to a partial repayment of an Intercompany Loan due from Babylon Canada to Babylon Partners Limited. The remaining amount of the Intercompany loan was forgiven immediately prior to the execution of the SPA.
Effect of disposal:
 
    
2021
 
    
$’000
 
Cash and cash equivalents
     (57
Prepayments and contract assets
     (1,322
Property, plant and equipment
     (922
Right-of-use
assets
     (797
    
2021
 
    
$’000
 
Trade and other receivables
     (619
Accruals and provisions
     658  
Lease liabilities
     837  
Borrowings
     3,075  
Trade and other payables
     588  
    
 
 
 
Net Assets and Liabilities Derecognised
  
 
1,441
 
    
 
 
 
Consideration Received
     2,344  
   
    
2021
 
    
$’000
 
Gain on Disposal
        
Consideration received
     2,344  
Net assets and liabilities derecognised
     1,441  
Working capital adjustment
     132  
    
 
 
 
Gain on disposal
  
 
3,917